Anti-CD45 pretargeted radioimmunotherapy using bismuth-213: high rates of complete remission and long-term survival in a mouse myeloid leukemia xenograft model.
暂无分享，去创建一个
F. Appelbaum | J. Pagel | D. Hamlin | D. Wilbur | D. Fisher | O. Press | T. Bäck | N. Orgun | Aimee L. Kenoyer | A. Gopal | Yukang Lin | Steven I. Park | Shani L. Frayo | J. Orozco | D. Green | J. Shenoi | Amanda Axtman | D. Green | D. Green